During the past decade, Ospedale Bolognini conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Bolognini" #1 sponsor was "Biotronik SE & Co. KG" with 2 trials, followed by "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored, "A. Manzoni Hospital" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Bolognini" #1 collaborator was "Agenzia Italiana del Farmaco" with 2 trials as a collaborator and "Medtronic Bakken Research Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Bolognini" are "Myocardial Infarction" (3 trials), "Diabetes" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cryptogenic Ischemic Stroke" (1 trials). Many other conditions were trialed in "Ospedale Bolognini" in a lesser frequency.

Most popular intervention types in "Ospedale Bolognini" are "Drug" (6 trials), "Device" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Benazepril" (2 trials), "Benazepril/Valsartan" (2 trials), "Everolimus Eluting Coronary Stent System" (2 trials), "Valsartan" (2 trials) and "Archival Tumor Tissue Sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Bolognini" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Bolognini". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ospedale Bolognini, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Bolognini, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".